Anti-pseudomonas IgY to Prevent Infections in Cystic Fibrosis
NCT00633191
·
clinicaltrials.gov ↗
PHASE1,PHASE2
Phase
COMPLETED
Status
14
Enrollment
OTHER
Sponsor class
Conditions
Cystic Fibrosis
Infection
Pseudomonas Aeruginosa
Interventions
DRUG:
Anti-pseudomonas IgY gargle
Sponsor
Immunsystem AB